Please login to the form below

Not currently logged in
Email:
Password:

BioCryst Appoints new senior vice-president of regulatory affairs

US-based BioCryst Pharmaceuticals hires Dr Elliott T Berger as senior vice-president of regulatory affairs

US-based BioCryst Pharmaceuticals has hired Dr Elliott T Berger as senior vice-president of regulatory affairs.

Dr Berger brings to BioCryst a long and successful track record in obtaining approval from the FDA for numerous drugs. He will play an integral role in BioCryst's planned clinical research programmes for treatments for influenza, leukaemia and lymphoma, autoimmune diseases and transplant rejection, and will work in close collaboration with health authorities in the US and other countries.

Berger has more than 30 years of experience in the pharmaceutical industry, including over 25 years devoted to management of regulatory affairs supporting new drug and biologic development. Most recently he was vice-president of regulatory affairs and quality assurance and head of global regulatory strategy at EMD Pharmaceuticals, the North American subsidiary of Germany-headquartered Merck KGaA.

Berger held a variety of research positions at Merck Research Laboratories in West Point, Pennsylvania, most recently as Senior Director, Regulatory Liaison. He has submitted and managed over 10 New Drug Applications and numerous Investigational Drug Applications in the areas of oncology, diabetes, cardiovascular disease, and neurology.

8th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Running
A marathon and a sprint
Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to compete...
5 tactics to master Market Access
Is it time to rethink your game plan? To succeed at Market Access, follow these 5 tactics:...
Finding the patient voice
How patients feel and speak about clinical trials...

Infographics